What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Myocardial infarction
James H. Chesebro mostly deals with Internal medicine, Cardiology, Platelet, Surgery and Thrombosis.
As a part of the same scientific family, James H. Chesebro mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Arachidonic acid.
His Cardiology study frequently draws connections between adjacent fields such as Randomized controlled trial.
His studies deal with areas such as Fibrinogen, Perfusion, Heparin and Tissue factor as well as Platelet.
His Surgery study combines topics in areas such as Silent Myocardial Infarction and Hazard ratio.
The concepts of his Thrombosis study are interwoven with issues in Thrombus and Antithrombotic.
His most cited work include:
- The pathogenesis of coronary artery disease and the acute coronary syndromes (1). (3515 citations)
- From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I (2483 citations)
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. (1915 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Thrombosis, Platelet and Myocardial infarction.
His research on Internal medicine often connects related areas such as Surgery.
His Cardiology study typically links adjacent topics like Anticoagulant.
His research investigates the connection with Thrombosis and areas like Pathogenesis which intersect with concerns in Disease.
The Platelet study combines topics in areas such as Vasoconstriction, Fibrinogen, Pharmacology and Tissue factor.
His study in Myocardial infarction is interdisciplinary in nature, drawing from both Ejection fraction, Sudden death, Ischemia and Fibrinolytic agent.
He most often published in these fields:
- Internal medicine (76.73%)
- Cardiology (69.09%)
- Thrombosis (29.82%)
What were the highlights of his more recent work (between 1999-2020)?
- Internal medicine (76.73%)
- Cardiology (69.09%)
- Thrombus (21.82%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cardiology, Thrombus, Myocardial infarction and Pharmacology.
His work on Coronary artery disease, Unstable angina and Aspirin as part of general Internal medicine study is frequently linked to Population, bridging the gap between disciplines.
James H. Chesebro has included themes like Left ventricular mass and Diastole in his Cardiology study.
His Thrombus research includes elements of Anesthesia, Antithrombotic, Heparin, Platelet and Thrombosis.
His Antithrombotic research is multidisciplinary, incorporating elements of Factor Xa Inhibitor and Pathology.
His Myocardial infarction research incorporates themes from Vulnerable plaque, Chest pain and Risk factor.
Between 1999 and 2020, his most popular works were:
- From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I (2483 citations)
- From Vulnerable Plaque to Vulnerable Patient (883 citations)
- Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging (447 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
Internal medicine, Thrombus, Endocrinology, Pathology and Aspirin are his primary areas of study.
His research on Internal medicine frequently connects to adjacent areas such as Cardiology.
His Thrombus research integrates issues from Tissue factor, Platelet, Heparin and Antithrombotic.
His Endocrinology study combines topics from a wide range of disciplines, such as Pharmacology and Thrombogenicity.
His research integrates issues of Arteriosclerosis, Fibrinogen and Vascular disease in his study of Pathology.
His Aspirin research is multidisciplinary, incorporating perspectives in Ibuprofen and Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
